Treatment of chronic myelogenous leukemia
From Proteopedia
(Difference between revisions)
| Line 2: | Line 2: | ||
*[[Imatinib]] | *[[Imatinib]] | ||
*[[Nilotinib]] | *[[Nilotinib]] | ||
| + | *[[Dasatinib]] | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:11, 20 February 2024
| |||||||||||
